Kane-Gill et al identified a number of risk factors associated with adverse drug events (ADE) in critically-ill patients. These can help to identify patients who may benefit from closer monitoring of their medications. The authors are from the University of Pittsburgh and Brigham and Women’s Hospital in Boston.